This HDAC induced cell death in HCC cells, and co-treatment with sorafenib had synergistic effects in mesenchymal HCC cells, which were resistant to sorafenib-induced apoptosis [201]. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.